Valuation GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. 04:35:08 08/09/2026 pm IST			5-day change	1st Jan Change
2,928.20 ^INR	-1.00%		-4.00%	+18.38%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,81,714	2,24,319	3,29,173	4,87,432	3,86,822	4,96,139	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	28.26%	-
Enterprise Value (EV)	2,56,351	2,07,663	3,29,173	4,87,432	3,86,822	4,96,139	4,96,139
Change	-	-18.99%	58.51%	48.08%	-20.64%	28.26%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	42.6x	37x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.7x	15.7x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.4x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.7x	10.5x
EV / Revenue	0x	0x	0x	0x	0x	11.7x	10.5x
EV / EBITDA	0x	0x	0x	0x	0x	33.4x	29.1x
EV / EBIT	0x	0x	0x	0x	0x	33.8x	29x
EV / FCF	0x	0x	0x	0x	0x	41.3x	37.7x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.42%	2.66%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.01%	1.01%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,928.70	2,928.70
Nbr of stocks (in thousands)	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.72x	11.9x	24.26x	0.6%	1,02400Cr
JOHNSON & JOHNSON	30.62x	-	-	1.95%	66TCr
ABBVIE INC.	32.73x	7.6x	15.8x	2.67%	45TCr
ROCHE HOLDING AG	19.22x	4.69x	11.6x	2.83%	35TCr
NOVARTIS AG	22.02x	5.68x	14.1x	2.82%	29TCr
ASTRAZENECA PLC	20.97x	4.3x	12.3x	2.05%	25TCr
AMGEN INC.	27.66x	7.14x	13.16x	2.31%	24TCr
NOVO NORDISK A/S	13.33x	4.82x	10.06x	3.78%	21TCr
GILEAD SCIENCES, INC.	-46.14x	6.65x	25.95x	2.18%	19TCr
Average	17.01x	6.60x	15.90x	2.35%	40.75TCr
Weighted average by Cap.	23.94x	7.98x	17.77x	1.96%